Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.34M | 6.92M | 9.36M | 7.97M | 12.01M |
Total Receivables | -- | -- | -- | -- | 40.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 621.20K | 302.60K | 319.30K | 570.20K | 1.04M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 162.50K | 142.90K | 98.30K | 104.70K | 104.60K |
Total Current Assets | 6.12M | 7.37M | 9.78M | 8.64M | 13.19M |
|
|||||
Total Current Assets | 6.12M | 7.37M | 9.78M | 8.64M | 13.19M |
Net Property, Plant & Equipment | 117.50K | 122.30K | 127.10K | 131.80K | 168.50K |
Long-term Investments | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
Goodwill | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
Total Other Intangibles | 7.15M | 7.31M | 7.47M | 7.63M | 7.78M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 14.66M | 16.06M | 18.64M | 17.66M | 22.41M |
|
|||||
Total Accounts Payable | 1.33M | 1.12M | 660.40K | 1.39M | 2.43M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | 33.00K |
Total Finance Division Other Current Liabilities | 269.00K | -- | -- | -- | -- |
Total Other Current Liabilities | 269.00K | -- | -- | -- | -- |
Total Current Liabilities | 1.59M | 1.12M | 660.40K | 1.39M | 2.47M |
|
|||||
Total Current Liabilities | 1.59M | 1.12M | 660.40K | 1.39M | 2.47M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 85.30K | 162.20K | 163.60K | 93.30K | 57.70K |
Total Liabilities | 1.68M | 1.28M | 824.00K | 1.49M | 2.52M |
|
|||||
Common Stock & APIC | 66.12M | 64.37M | 64.25M | 59.23M | 59.07M |
Retained Earnings | -53.15M | -49.58M | -46.41M | -43.05M | -39.18M |
Treasury Stock & Other | -- | -7.20K | -35.30K | -8.20K | -5.30K |
Total Common Equity | 12.98M | 14.78M | 17.81M | 16.18M | 19.88M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 12.98M | 14.78M | 17.81M | 16.18M | 19.88M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 12.98M | 14.78M | 17.81M | 16.18M | 19.88M |
|